Literature DB >> 2531196

Lymphokine regulation of CD45R expression on human T cell clones.

S A Brod1, C E Rudd, M Purvee, D A Hafler.   

Abstract

Whether the expression of higher molecular weight isoforms of the T-200 complex represents different lineages of T cells and/or a sequential stage of the differential pathway of T cells has been unclear. Understanding T cell expression of higher molecular weight isoforms of the T-200 complex (CD45R) may be important because of their association with regulation of immune responses. By direct single cell cloning, we observed a number of long-term T cell clones that expressed CD45RA (2H4). CD45RA expression could be further regulated by ionomycin or the cytokines IL-1 and IL-6, but not IL-2, IL-4, or IFN-gamma. These results indicate that CD45RA expression may define T cell lineages of activated T cells partially controlled by the cytokines IL-1 and IL-6. Further, these results may associate regulatory actions of IL-1 and IL-6 with their ability to increase CD45RA expression in subpopulations of human T cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2531196      PMCID: PMC2189525          DOI: 10.1084/jem.170.6.2147

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells.

Authors:  A N Akbar; L Terry; A Timms; P C Beverley; G Janossy
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

2.  The functionally distinct subpopulations of human CD4+ helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent post-thymic differentiation.

Authors:  L T Clement; N Yamashita; A M Martin
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

3.  Structural studies of murine lymphocyte surface IgD.

Authors:  J W Goding
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

Review 4.  Molecular interactions, T-cell subsets and a role of the CD4/CD8:p56lck complex in human T-cell activation.

Authors:  C E Rudd; P Anderson; C Morimoto; M Streuli; S F Schlossman
Journal:  Immunol Rev       Date:  1989-10       Impact factor: 12.988

5.  The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck.

Authors:  A Veillette; M A Bookman; E M Horak; J B Bolen
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

6.  Evidence from cDNA clones that the rat leukocyte-common antigen (T200) spans the lipid bilayer and contains a cytoplasmic domain of 80,000 Mr.

Authors:  M L Thomas; A N Barclay; J Gagnon; A F Williams
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

7.  The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes.

Authors:  C E Rudd; J M Trevillyan; J D Dasgupta; L L Wong; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

8.  Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production.

Authors:  M E Sanders; M W Makgoba; S O Sharrow; D Stephany; T A Springer; H A Young; S Shaw
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

9.  Identification of the sequence required for expression of the 2H4 epitope on the human leukocyte common antigens.

Authors:  M Streuli; T Matsuyama; C Morimoto; S F Schlossman; H Saito
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  The subdivision of the T4 (CD4) subset on the basis of the differential expression of L-C/T200 antigens.

Authors:  C E Rudd; C Morimoto; L L Wong; S F Schlossman
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Isoforms of the CD45 common leukocyte antigen family: markers for human T-cell differentiation.

Authors:  L T Clement
Journal:  J Clin Immunol       Date:  1992-01       Impact factor: 8.317

2.  Loss of activation-induced CD45RO with maintenance of CD45RA expression during prolonged culture of T cells and NK cells.

Authors:  H S Warren; L J Skipsey
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

3.  Identical expression of CD45R isoforms by CD45RC+ 'revertant' memory and CD45RC+ naive CD4 T cells.

Authors:  M Hargreaves; E B Bell
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

4.  Putative role for interleukin-7 in the maintenance of the recirculating naive CD4+ T-cell pool.

Authors:  L M Webb; B M Foxwell; M Feldmann
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

5.  Rapid conversion of naive to effector T cell function counteracts diminished primary human newborn T cell responses.

Authors:  E Early; D J Reen
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

6.  CD31 (PECAM-1) is a differentiation antigen lost during human CD4 T-cell maturation into Th1 or Th2 effector cells.

Authors:  C E Demeure; D G Byun; L P Yang; N Vezzio; G Delespesse
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

Review 7.  FOXP3+ regulatory T cells in the human immune system.

Authors:  Shimon Sakaguchi; Makoto Miyara; Cristina M Costantino; David A Hafler
Journal:  Nat Rev Immunol       Date:  2010-06-18       Impact factor: 53.106

8.  IL-2 infusion abrogates humoral immune responses in humans.

Authors:  D J Gottlieb; H G Prentice; H E Heslop; C Bello; M K Brenner
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

9.  Allelic variant in CTLA4 alters T cell phosphorylation patterns.

Authors:  Lisa M Maier; David E Anderson; Philip L De Jager; Linda S Wicker; David A Hafler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-13       Impact factor: 11.205

10.  Presence of T-cell subset abnormalities in newly diagnosed cases of multiple sclerosis and relationship with short-term clinical activity.

Authors:  M Eoli; M Ferrarini; A Dufour; S Heltaj; L Bevilacqua; G Comi; V Cosi; G Filippini; V Martinelli; C Milanese
Journal:  J Neurol       Date:  1993-02       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.